Sentences with word «cefovecin»

Effectiveness and safety of cefovecin sodium, an extended - spectrum injectable cephalosporin, in the treatment of cats with abscesses and infected wounds.

Despite the high cost of cefovecin in Turkey, its effectiveness and usefulness have been discussed in this study.

Efficacy and safety of cefovecin in treating bacterial folliculitis, abscesses, or infected wounds in dogs.

Stegemann et al. [4] have reported that cefovecin showed good activity against Gram - negative organisms isolated from dogs and cats, including Escherichia coli, Pasteurella multocida, Klebsiella spp. (including K. pneumonia), Enterobacter spp. and anaerobic - growing pathogens Fusobacterium spp., Bacteriodes spp., Prevotella oralis.

It is the first study on in vitro activity of cefovecin against bacterial isolates from cats with lower urinary infections in Istanbul, Turkey.

Recently, Zoetis, formerly Pfizer Animal Health, has released cefovecin, a single injection of which lasts 2 weeks.

CONVENIA Injectable 10 mL multi-use vial containing 800 milligrams of cefovecin as a lyophilized cake.

Stegemann et al. [4] reported that cefovecin exhibited a broad activity against a range of Gram - negative pathogens and was not active in vitro against P. aeruginosa.

Because cefovecin is a new antimicrobial agent in veterinary medicine, there are only few studies about urine culture of cats with LUTI.

The zone of inhibition around the disk (30 μg cefovecin) was measured.

These responded to cefovecin injections, but no further workup had been done.

Wright AK, Fadok V, Amodie D. First treatment success with injectable cefovecin sodium in dogs for superficial pyoderma, wounds, and abscesses in different dog populations.

My preference is amoxicillin - clavulanic acid (Clavamox); however, there is an injectible antibiotic formulation called cefovecin (Convenia) in which one injection under the skin provides an entire 14 - day course of treatment and is especially useful in cats that resent oral medication (i.e., every cat on Earth).

Cefovecin sodium [Convenia ®; Pfizer Animal Health; USA] is a newly developed, semi-synthetic, extended - spectrum injectable third - generation cephalosporin administered at 8 mg / kg subcutaneously (SC) for the treatment of UTI and skin and soft tissue infections in dogs and cats and it has been approved for subcutaneous (SC) injections in cats since 2006 in EU and 2008 in USA [4,6 - 9].

Wernick and Müntener [5] have reported that cefovecin showed no bactericidal activity against Enterococcus spp. but it is active against Arcanobacterium renale.

Background: The aim of this study was to determine the bacterial species recovered from 61 cats with lower urinary tract infection (LUTI), and their susceptibility to cefovecin in vitro.

The antimicrobial activity of cefovecin is similar to that of other cephalosporin antibiotics, which share low toxicity and good activity against many Gram - positive and Gram - negative aerobic bacteria [6].

In obstinate cats, an injectable form of Cefovecin is available that lasts for a full week.

CONVENIA (cefovecin sodium) is an injectable antimicrobial indicated for the treatment of canine skin infections (secondary superficial pyoderma, abscesses, and wounds) caused by susceptible strains of Staphylococcus intermedius and Streptococcus canis (Group G).

Convenia ® (cefovecin sodium)- The first anti-infective for the treatment of common bacterial skin infections in cats that provides an entire course of treatment in a single injection.

Make sure everyone in your clinic has access to the CONVENIA ® (cefovecin sodium) dosing chart and efficacy information.

Conclusion: Cefovecin was found to be effective in cats with LUTI.

Keywords: Cat, Urinary tract infection, Urine culture, Antimicrobial susceptibility, Cefovecin

MADISON, New Jersey, January 23, 2012 — The Food and Drug Administration (FDA - CVM) has approved a new product label for Convenia ® (cefovecin sodium), the single - injection cephalosporin for treatment of common canine and feline bacterial skin infections.

Stegemann et al. [4] reported that cefovecin was not appreciably active against Enterococcus spp., although in this study E. faecalis isolates were found to be susceptible in vitro.

Antimicrobial susceptibility tests showed that 13 of 16 (81 %) isolates were susceptible to cefovecin.

Our results (81 % of isolates susceptible to cefovecin) are in agreement with these findings.

Cefovecin has been specifically developed for the animal practice as a long - acting third - generation cephalosporin with duration of action of 14 days.

Antimicrobial susceptibility tests results showed that 13 of 16 (81 %) isolates were susceptible to cefovecin.

However, E. avium isolate was found to be resistant, and Arcanobacterium renale isolate to be of intermediate susceptible to cefovecin.

While literature suggests good activity of cefovecin against coagulasenegative staphylococci, in this study S. epidermidis isolate was resistant to cefovecin [4,8].

Cefovecin is one of the antimicrobial agents that can be used in lower urinary tract infections and it is easy to administer a single injection.

The aim of this study was to determine the bacterial species recovered from cats with LUTI, and their susceptibility to cefovecin in vitro.

In a double - blind study, 86 % of dogs treated with CONVENIA ® (cefovecin sodium) required just 1 injection.3

Ninety - six percent of pet owners said they would use CONVENIA ® (cefovecin sodium) again if their veterinarian recommended it.5

These products include the recently announced conditional license for Canine Atopic Dermatitis Immunotherapeutic *, a first - of - its - kind antibody therapy to help reduce clinical signs associated with atopic dermatitis in dogs, as well as APOQUEL ® (oclacitinib tablet) and CONVENIA ® (cefovecin sodium).

Besides the Clavamox / Augmentin (Amoxiciilin & Clavulanic acid) antibiotic mentioned in the prior reference, veterinarians often administer periodic Convenia (cefovecin) antibiotic injections or rely on doxyclcyline.